These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33136345)

  • 1. Putting morphology to the test: An established classification scheme reliably stratifies salivary gland cytology by risk of malignancy with substantial interobserver agreement.
    Lubin DJ; Griffith CC; Buonocore DJ; Wei XJ; Lin O
    Cancer Cytopathol; 2021 Apr; 129(4):291-303. PubMed ID: 33136345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the Milan System for Reporting Salivary Gland Cytopathology: Experience of an academic institution in a tertiary academic medical center.
    Castrodad-Rodríguez CA; Lajara S; Khader SN; Colanta AB; Guerrero DR; El Hussein S; Hakima L
    Cancer Cytopathol; 2021 Mar; 129(3):204-213. PubMed ID: 33030811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Northern Italy in the American South: Assessing interobserver reliability within the Milan System for Reporting Salivary Gland Cytopathology.
    Hollyfield JM; O'Connor SM; Maygarden SJ; Greene KG; Scanga LR; Tang S; Dodd LG; Wobker SE
    Cancer Cytopathol; 2018 Jun; 126(6):390-396. PubMed ID: 29579353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary gland neoplasms with basaloid features in the era of the Milan system for reporting salivary gland cytology: Classification and interobserver agreement.
    Layfield LJ; Esebua M; Pantanowitz L; Maleki Z; Vazmitsel M; Baloch Z; Cantley RL; Schmidt R
    Diagn Cytopathol; 2022 Jul; 50(7):341-349. PubMed ID: 35460214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-institutional validation of a modified scheme for subcategorizing salivary gland neoplasm of uncertain malignant potential (SUMP).
    Hang JF; Lee JJL; Nga ME; Higuchi K; Hirata Y; Wu HH; Allison DB; Gilbert JD; Lin O; Saieg M; de Arruda AF; Chen YA; Huang EC; Manucha V
    Cancer Cytopathol; 2022 Jul; 130(7):511-522. PubMed ID: 35637575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the diagnostic accuracy for pleomorphic adenoma and Warthin tumor by employing the Milan System for Reporting Salivary Gland Cytopathology: An international, multi-institutional study.
    Allison DB; Smith AP; An D; Miller JA; Shafique K; Song S; Viswanathan K; Eykman E; Rao RA; Wiles A; Barkan GA; Nayar R; Fadda G; Powers CN; Rossi ED; Siddiqui MT; Ali SZ; Kholová I; Layfield LJ; Field A; Baloch Z; Maleki Z
    Cancer Cytopathol; 2021 Jan; 129(1):43-52. PubMed ID: 32767837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Milan System for Reporting Salivary Gland Cytopathology.
    Hindi I; Simsir A; Szeto O; Hernandez O; Sun W; Zhou F; Brandler TC
    Am J Clin Pathol; 2022 Nov; 158(5):583-597. PubMed ID: 35849113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of histologic follow-up and risk of malignancy for salivary gland neoplasm of uncertain malignant potential proposed by the Milan System for Reporting Salivary Gland Cytopathology.
    Liu H; Ljungren C; Lin F; Zarka MA; Chen L
    Cancer Cytopathol; 2018 Jul; 126(7):490-497. PubMed ID: 29669190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the Milan System for Reporting Salivary Gland Cytopathology: A 5-year institutional experience.
    Viswanathan K; Sung S; Scognamiglio T; Yang GCH; Siddiqui MT; Rao RA
    Cancer Cytopathol; 2018 Aug; 126(8):541-551. PubMed ID: 29797690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-Needle Aspiration Cytology of Cellular Basaloid Neoplasms of the Salivary Gland.
    Cantley RL
    Arch Pathol Lab Med; 2019 Nov; 143(11):1338-1345. PubMed ID: 31509452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Milan System for Reporting Salivary Gland Cytopathology: Assessment of Cytohistological Concordance and Risk of Malignancy.
    Jha S; Mitra S; Purkait S; Adhya AK
    Acta Cytol; 2021; 65(1):27-39. PubMed ID: 33045705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of Milan system for reporting salivary gland cytopathology: A prospective study.
    Hosseini SM; Resta IT; Baloch ZW
    Diagn Cytopathol; 2021 Jul; 49(7):822-831. PubMed ID: 33823076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pattern-based risk-stratification scheme for salivary gland cytology: A multi-institutional, interobserver variability study to determine applicability.
    Griffith CC; Schmitt AC; Pantanowitz L; Monaco SE
    Cancer Cytopathol; 2017 Oct; 125(10):776-785. PubMed ID: 28834233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtyping salivary gland neoplasm of uncertain malignant potential based on cell type demonstrates differential risk of malignancy.
    Hang JF; Alruwaii F; Zeng BR; Lai CR; Wu HH
    Cancer Cytopathol; 2018 Nov; 126(11):924-933. PubMed ID: 30335220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver variability between cytopathologists and cytotechnologists upon application and characterization of the indeterminate category in the Milan System for Reporting Salivary Gland Cytopathology.
    Viswanathan K; Patel A; Abdelsayed M; Rosado L; Soong L; Margolskee E; Heymann JJ; Goyal A; Rao RA
    Cancer Cytopathol; 2020 Nov; 128(11):828-839. PubMed ID: 32573971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of malignancy associated with cytomorphology subtypes in the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan System: A bi-institutional study.
    Chowsilpa S; An D; Lose H; Huang X; Nayar R; Maleki Z
    Cancer Cytopathol; 2019 Jun; 127(6):377-389. PubMed ID: 31116514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milan Interobserver Reproducibility Study (MIRST): Milan System 2018.
    Kurtycz DFI; Rossi ED; Baloch Z; Pavelec D; Madrigal E; Vielh P; Faquin W
    J Am Soc Cytopathol; 2020; 9(3):116-125. PubMed ID: 32171680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective comparison of salivary gland fine needle aspiration reporting with the Milan system for reporting salivary gland cytology.
    Mullen D; Gibbons D
    Cytopathology; 2020 May; 31(3):208-214. PubMed ID: 32061105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectuation to Cognize malignancy risk and accuracy of fine needle aspiration cytology in salivary gland using "Milan System for Reporting Salivary Gland Cytopathology": A 2 years retrospective study in academic institution.
    Karuna V; Gupta P; Rathi M; Grover K; Nigam JS; Verma N
    Indian J Pathol Microbiol; 2019; 62(1):11-16. PubMed ID: 30706853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the risk of malignancy associated with the basaloid and oncocytic subtypes of the salivary gland neoplasm of unknown malignant potential (SUMP) category in the Milan system.
    Manucha V; Gonzalez MF; Akhtar I
    Cancer Cytopathol; 2021 Aug; 129(8):603-611. PubMed ID: 33788998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.